Effect of a leucine-rich repeat kinase 2 variant on motor and non-motor symptoms in Chinese Parkinson's disease patients

Aging and Disease

Volumn 7, Issue 3, 2016, Pages 230-236

  Sun, Qian ^a   Wang, Tian ^a   Jiang, Tian Fang ^a   Huang, Pei ^a   Li, Dun Hui ^a   Wang, Ying ^a   Xiao, Qin ^a   Liu, Jun ^a   Chen, Sheng Di ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

G2385R; LRRK2; Motor symptoms; Non motor symptoms; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN DEPTH STIMULATION; CHIN TREMOR; COGNITION; COGNITIVE DEFECT; DISEASE SEVERITY; DNA EXTRACTION; DYSKINESIA; FALLING; FEMALE; FREEZING; GAIT; GENETIC ANALYSIS; GENOTYPE; HAMILTON DEPRESSION RATING SCALE; HOEHN AND YAHR SCALE; HUMAN; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MOTONEURON; NON MOTOR SYMPTOMS QUESTIONNAIRE; PARKINSON DISEASE; PHENOTYPE; POSTURAL TREMOR; PREVALENCE; REM SLEEP BEHAVIOR DISORDER SCREENING QUESTIONNAIRE; RISK FACTOR; TREMOR; WALKING;

EID: 85007355210     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2015.1026     Document Type: Article

References (33)

1. Tolleson CM, Fang JY (2013). Advances in the mechanisms of Parkinson's disease. Discov Med, 15:61-66.
2. Peeraully T, Tan EK (2012). Genetic variants in sporadic Parkinson's disease: East vs West. Parkinsonism Relat Disord, 18 Suppl 1:S63-65.
3. An XK, Peng R, Li T, Burgunder JM, Wu Y, Chen WJ, et al (2008). LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China. Eur J Neurol, 15:301-305.
4. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, et al (2008). Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol, 7:583-590.
5. Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, Kisselev S, et al (2009). Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol, 66:1517-1522.
6. Wang C, Cai Y, Gu Z, Ma J, Zheng Z, Tang BS, et al (2014). Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals. Neurobiol Aging, 35:725 e1-6.
7. Gao C, Pang H, Luo XG, Ren Y, Shang H, He ZY (2013). LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation. J Neurol, 260:2884-2889.
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry, 55:181-184.
9. Li C, Ting Z, Qin X, Ying W, Li B, Guo Qiang L, et al (2007). The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease. Mov Disord, 22:2439-2443.
10. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, et al (1990). Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology, 40:1529-1534.
11. Schrag A, Quinn N (2000). Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain, 123:2297-2305.
12. Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, et al (2006). International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord, 21:916-923.
13. Chen W, Tan YY, Hu YY, Zhan WW, Wu L, Lou Y, et al (2012). Combination of olfactory test and substantia nigra transcranial sonopraphy in the differential diagnosis of Parkinson's disease: a pilot study from China. Transl Neurodegener, 1:25.
14. Chen W, Chen S, Kang WY, Li B, Xu ZM, Xiao Q, et al (2012). Application of odor identification test in Parkinson's disease in China: a matched case-control study. J Neurol Sci, 316:47-50.
15. Folstein MF, Folstein SE, McHugh PR (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12:189-198.
16. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry, 48:851-855.
17. Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH (2007). The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument. Mov Disord, 22:2386-2393.
18. Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K (2011). Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson's disease patients. Sleep Med, 12:711-713.
19. Wang C, Cai Y, Zheng Z, Tang BS, Xu Y, Wang T, et al (2012). Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. Parkinsonism Relat Disord, 18:958-963.
20. Funayama M, Li Y, Tomiyama H, Yoshino H, Imamichi Y, Yamamoto M, et al (2007). Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Neuroreport, 18:273-275.
21. Kim JM, Lee JY, Kim HJ, Kim JS, Shin ES, Cho JH, et al (2010). The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population. Parkinsonism Relat Disord, 16:85-88.
22. Fung HC, Chen CM, Hardy J, Singleton AB, Wu YR (2006). A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. BMC Neurol, 6:47.
23. Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, et al (2009). Clinical features in early Parkinson disease and survival. Arch Neurol, 66:1353-1358.
24. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D (2006). Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord, 21:1123-1130.
25. Allcock LM, Kenny RA, Burn DJ (2006). Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension: autonomic symptom and demographic comparison. Mov Disord, 21:1851-1855.
26. Marras C, Schule B, Munhoz RP, Rogaeva E, Langston JW, Kasten M, et al (2011). Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology, 77:325-333.
27. Mirelman A, Heman T, Yasinovsky K, Thaler A, Gurevich T, Marder K, et al (2013). Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation. Mov Disord, 28:1683-1690.
28. Gan-Or Z, Bar-Shira A, Mirelman A, Gurevich T, Kedmi M, Giladi N, et al (2010). LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. Neurogenetics, 11:121-125.
29. Hao M, Pan N, Zhang Q, Wang X (2014). Mutant of leucine-rich repeat kinase 2 is not associated with non-motor symptoms in Chinese Parkinson's disease patients. Int J Clin Exp Med, 7:2253-2257.
30. Li DW, Gu Z, Wang C, Ma J, Tang BS, Chen SD, et al (2015). Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants. J Neural Transm, 122:661-667.
31. Kumru H, Santamaria J, Tolosa E, Iranzo A (2007). Relation between subtype of Parkinson's disease and REM sleep behavior disorder. Sleep Med, 8:779-783.
32. Postuma RB, Gagnon JF, Vendette M, Charland K, Montplaisir J (2008). REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features. J Neurol Neurosurg Psychiatry, 79:1117-1121.
33. Ozekmekci S, Apaydin H, Kilic E (2005). Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder. Clin Neurol Neurosurg, 107:306-309.